Antithrombotic-Associated Bleeding: Management in the Emergency Department (Pharmacology CME and Risk Management CME) | Store
Click to check your cart0

Antithrombotic-Associated Bleeding: Management in the Emergency Department (Pharmacology CME and Risk Management CME)

Antithrombotic-Associated Bleeding: Management in the Emergency Department (Pharmacology CME and Risk Management CME)
Enlarge Image
Delivery Method:
$99.00
ADD TO CART

Publication Date: October 2026 (Volume 28, Number 10)

CME Credits: 4 AMA PRA Category 1 Credits™, 4 ACEP Category I credits, 4 AAFP Prescribed credits, and 4 AOA Category 2-B CME credits. CME expires 10/01/2029.

Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 4 Pharmacology CME credits and 0.25 Risk Management CME credits, subject to your state and institutional approval.

Authors

Xin Qi, MD
Department of Emergency Medicine, Mass General Brigham, Boston, MA
Annie Leamon, MD
Department of Emergency Medicine, Mass General Brigham, Boston, MA
Christopher Baugh, MD, MBA
Associate Professor, Harvard Medical School; Attending Physician, Department of Emergency Medicine, Brigham and Women’s Hospital, Boston, MA

Abstract

The expanding use of antiplatelet agents, anticoagulants, and fibrinolytics has made bleeding emergencies more frequent and more complex. A structured, evidence-based approach enables emergency clinicians to identify life-threatening and critical-site bleeding, initiate resuscitation, establish which antithrombotic agent the patient received and when, and weigh the benefit of restoring hemostasis against the risk for thrombosis. This review synthesizes current guidelines and evidence on the evaluation and management of bleeding in patients receiving antithrombotic therapy, identifying areas of consensus and ongoing uncertainty. Coagulation assays, agent-specific reversal and hemostatic strategies, periprocedural management, and bleeding in pregnancy are addressed.

Case Presentations

CASE 1

A 65-year-old woman presents to a critical access hospital ED after being a passenger in a high-speed motor vehicle crash…

  • On arrival, her Glasgow Coma Scale score is 14. Her blood pressure is 90/60 mm Hg, and her heart rate is 115 beats/min. She reports taking warfarin for a mechanical heart valve.
  • A FAST examination is positive for free fluid in the abdomen.
  • One unit of emergency-release O-positive PRBC is transfused through a large-bore IV catheter.
  • As you initiate transfer to a higher-level trauma center, the patient becomes drowsy, and her blood pressure decreases to 80/50 mm Hg.
  • You wonder if you should reverse the effects of warfarin despite the presence of a mechanical heart valve…
CASE 2

A 40-year-old man with a history of cirrhosis presents with hematemesis…

  • He reports 2 episodes of bright-red blood hematemesis and 1 episode of melena over the past 3 hours.
  • His blood pressure is 100/40 mm Hg, and his heart rate is 132 beats/min. He is pale and diaphoretic.
  • His medical record notes a recent admission for thrombosis of a transjugular intrahepatic portosystemic shunt. He is receiving therapeutic enoxaparin, with his last dose taken approximately 3 hours ago.
  • His initial hemoglobin level is 5 g/dL. He receives emergency-release O-positive PRBC.
  • You wonder whether enoxaparin can be effectively reversed…
CASE 3

A 60-year-old woman presents to a community ED after being found obtunded in bed. She was last seen normal approximately 10 hours ago…

  • Her Glasgow Coma Scale score is 8, with flaccidity of the right upper and lower extremities. Her initial blood pressure is 195/105 mm Hg.
  • The patient’s medical history includes atrial fibrillation and recent coronary artery stenting. Her chart lists clopidogrel and apixaban, but the timing of her last doses is unknown.
  • Noncontrast CT of the head shows a large intraparenchymal hemorrhage with intraventricular extension and mass effect.
  • The neurosurgery team is planning for operative management and recommends platelet transfusion. You wonder whether platelet transfusion is indicated…

Accreditation:

EB Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Product Reviews

Very helpful for this difficult and confusing topic.
James Jessen, MD - 11/10/2026
A very well researched and well written article.
Abdul Moheet, MD - 10/19/2026